At the time of writing, uniQure N.V. [QURE] stock is trading at $8.34, down -2.74%. An important factor to consider is whether the stock is rising or falling in short-term value. The QURE shares have gain 7.69% over the last week, with a monthly amount glided 89.43%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
uniQure N.V. [NASDAQ: QURE] stock has seen the most recent analyst activity on February 29, 2024, when Goldman downgraded its rating to a Neutral but kept the price target unchanged to $8 for it. Previously, Mizuho downgraded its rating to Neutral on December 19, 2023, and dropped its price target to $10. On March 17, 2022, upgrade upgraded it’s rating to Buy but maintained its price target of $40 on the stock. BTIG Research started tracking the stock assigning a Buy rating and suggested a price target of $46 on June 15, 2021. UBS initiated its recommendation with a Neutral and recommended $40 as its price target on May 21, 2021. In a note dated April 01, 2021, Mizuho upgraded an Buy rating on this stock but restated the target price of $52.
For the past year, the stock price of uniQure N.V. fluctuated between $3.73 and $11.35. Currently, Wall Street analysts expect the stock to reach $53.67 within the next 12 months. uniQure N.V. [NASDAQ: QURE] shares were valued at $8.34 at the most recent close of the market. An investor can expect a potential return of 543.53% based on the average QURE price forecast.
Analyzing the QURE fundamentals
According to uniQure N.V. [NASDAQ:QURE], the company’s sales were 19.00M for trailing twelve months, which represents an 59.34% jump. Gross Profit Margin for this corporation currently stands at -0.21% with Operating Profit Margin at -13.9%, Pretax Profit Margin comes in at -15.42%, and Net Profit Margin reading is -15.62%. To continue investigating profitability, this company’s Return on Assets is posted at -0.39, Equity is -1.22 and Total Capital is -0.37. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 3.51.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 8.09 points at the first support level, and at 7.85 for the second support level. However, for the 1st resistance point, the stock is sitting at 8.63, and for the 2nd resistance point, it is at 8.93.
Ratios To Look Out For
It is important to note that uniQure N.V. [NASDAQ:QURE] has a current ratio of 9.39. On the other hand, the Quick Ratio is 9.27, and the Cash Ratio is 3.83. Considering the valuation of this stock, the price to sales ratio is 21.30, the price to book ratio is 2.75.
Transactions by insiders
Recent insider trading involved Abi-Saab Walid, Chief Medical Officer, that happened on Jun 26 ’24 when 1447.0 shares were sold. Chief Operating Officer, CALOZ PIERRE completed a deal on Jun 17 ’24 to sell 2936.0 shares. Meanwhile, Chief Financial Officer KLEMT CHRISTIAN sold 1611.0 shares on Jun 17 ’24.
